Loading…
Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department
Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and Apri...
Saved in:
Published in: | Acute medicine & surgery 2024-01, Vol.11 (1), p.e934-n/a |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53 |
container_end_page | n/a |
container_issue | 1 |
container_start_page | e934 |
container_title | Acute medicine & surgery |
container_volume | 11 |
creator | Mihara, Yutaka Komoriya, Kenta Hagiwara, Kei Hatanaka, Yasuhito Shibahashi, Keita Hikone, Mayu Sugiyama, Kazuhiro |
description | Aim
FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department.
Methods
Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis.
Results
A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p |
doi_str_mv | 10.1002/ams2.934 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4</doaj_id><sourcerecordid>3150086566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</originalsourceid><addsrcrecordid>eNp1ks1u1DAQxyMEolWpxBMgS1y4pIw_4jgntFpRqFTEAThb_hgvXiXx4iRF-1I8BE-Gly2lReJky_PTT3_PTFU9p3BBAdhrM0zsouPiUXXKoGG1UrR9fO9-Up1P0xYAKAUuJX1anXAlGgDOTyu9cm7Jxu1JCiSbXfTE9il54pLZLL2ZYxrJjNMcxw3xeBMdksto1ybjzx8kjsSUap6jyXuCA-YNjsXlcWfyPOA4P6ueBNNPeH57nlVfLt9-Xr-vrz--u1qvrmvHOylqz2QwtPFdy1qukCOAFKFx0FKl0PAgaPCSMSWDKOF9Y43lTKFtJTqwDT-rro5en8xW73IcSiKdTNS_H1Le6JIouh61YyIEaJF3IgiLaC1I04IR3qAXKIrrzdG1W-yA3pVvZNM_kD6sjPGr3qQbTaGjUra8GF7dGnL6tpTu6SFODvvejJiWSbNOMKq6RkJBX_6DbtOSx9IrzWkZkpKNlH-FLqdpyhju0lDQhy3Qhy3QZQsK-uJ--jvwz8wLUB-B77HH_X9FevXhEzsIfwE88rys</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3150086566</pqid></control><display><type>article</type><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</creator><creatorcontrib>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</creatorcontrib><description>Aim
FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department.
Methods
Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis.
Results
A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p < 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma.
Conclusions
FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.
FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</description><identifier>ISSN: 2052-8817</identifier><identifier>EISSN: 2052-8817</identifier><identifier>DOI: 10.1002/ams2.934</identifier><identifier>PMID: 38450033</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Accuracy ; blood coagulation ; diagnosis ; Emergency medical care ; emergency room ; fibrinogen ; Hemorrhage ; Molecular weight ; Original ; Patients ; Plasma ; Postpartum period ; trauma ; Viscoelasticity</subject><ispartof>Acute medicine & surgery, 2024-01, Vol.11 (1), p.e934-n/a</ispartof><rights>2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.</rights><rights>2024 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</cites><orcidid>0009-0007-1004-9659 ; 0000-0001-5651-1449 ; 0000-0003-4104-386X ; 0009-0009-9980-1185</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3150086566/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3150086566?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38450033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mihara, Yutaka</creatorcontrib><creatorcontrib>Komoriya, Kenta</creatorcontrib><creatorcontrib>Hagiwara, Kei</creatorcontrib><creatorcontrib>Hatanaka, Yasuhito</creatorcontrib><creatorcontrib>Shibahashi, Keita</creatorcontrib><creatorcontrib>Hikone, Mayu</creatorcontrib><creatorcontrib>Sugiyama, Kazuhiro</creatorcontrib><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><title>Acute medicine & surgery</title><addtitle>Acute Med Surg</addtitle><description>Aim
FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department.
Methods
Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis.
Results
A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p < 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma.
Conclusions
FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.
FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</description><subject>Accuracy</subject><subject>blood coagulation</subject><subject>diagnosis</subject><subject>Emergency medical care</subject><subject>emergency room</subject><subject>fibrinogen</subject><subject>Hemorrhage</subject><subject>Molecular weight</subject><subject>Original</subject><subject>Patients</subject><subject>Plasma</subject><subject>Postpartum period</subject><subject>trauma</subject><subject>Viscoelasticity</subject><issn>2052-8817</issn><issn>2052-8817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks1u1DAQxyMEolWpxBMgS1y4pIw_4jgntFpRqFTEAThb_hgvXiXx4iRF-1I8BE-Gly2lReJky_PTT3_PTFU9p3BBAdhrM0zsouPiUXXKoGG1UrR9fO9-Up1P0xYAKAUuJX1anXAlGgDOTyu9cm7Jxu1JCiSbXfTE9il54pLZLL2ZYxrJjNMcxw3xeBMdksto1ybjzx8kjsSUap6jyXuCA-YNjsXlcWfyPOA4P6ueBNNPeH57nlVfLt9-Xr-vrz--u1qvrmvHOylqz2QwtPFdy1qukCOAFKFx0FKl0PAgaPCSMSWDKOF9Y43lTKFtJTqwDT-rro5en8xW73IcSiKdTNS_H1Le6JIouh61YyIEaJF3IgiLaC1I04IR3qAXKIrrzdG1W-yA3pVvZNM_kD6sjPGr3qQbTaGjUra8GF7dGnL6tpTu6SFODvvejJiWSbNOMKq6RkJBX_6DbtOSx9IrzWkZkpKNlH-FLqdpyhju0lDQhy3Qhy3QZQsK-uJ--jvwz8wLUB-B77HH_X9FevXhEzsIfwE88rys</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Mihara, Yutaka</creator><creator>Komoriya, Kenta</creator><creator>Hagiwara, Kei</creator><creator>Hatanaka, Yasuhito</creator><creator>Shibahashi, Keita</creator><creator>Hikone, Mayu</creator><creator>Sugiyama, Kazuhiro</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0007-1004-9659</orcidid><orcidid>https://orcid.org/0000-0001-5651-1449</orcidid><orcidid>https://orcid.org/0000-0003-4104-386X</orcidid><orcidid>https://orcid.org/0009-0009-9980-1185</orcidid></search><sort><creationdate>202401</creationdate><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><author>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>blood coagulation</topic><topic>diagnosis</topic><topic>Emergency medical care</topic><topic>emergency room</topic><topic>fibrinogen</topic><topic>Hemorrhage</topic><topic>Molecular weight</topic><topic>Original</topic><topic>Patients</topic><topic>Plasma</topic><topic>Postpartum period</topic><topic>trauma</topic><topic>Viscoelasticity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mihara, Yutaka</creatorcontrib><creatorcontrib>Komoriya, Kenta</creatorcontrib><creatorcontrib>Hagiwara, Kei</creatorcontrib><creatorcontrib>Hatanaka, Yasuhito</creatorcontrib><creatorcontrib>Shibahashi, Keita</creatorcontrib><creatorcontrib>Hikone, Mayu</creatorcontrib><creatorcontrib>Sugiyama, Kazuhiro</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Acute medicine & surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mihara, Yutaka</au><au>Komoriya, Kenta</au><au>Hagiwara, Kei</au><au>Hatanaka, Yasuhito</au><au>Shibahashi, Keita</au><au>Hikone, Mayu</au><au>Sugiyama, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</atitle><jtitle>Acute medicine & surgery</jtitle><addtitle>Acute Med Surg</addtitle><date>2024-01</date><risdate>2024</risdate><volume>11</volume><issue>1</issue><spage>e934</spage><epage>n/a</epage><pages>e934-n/a</pages><issn>2052-8817</issn><eissn>2052-8817</eissn><abstract>Aim
FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department.
Methods
Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis.
Results
A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p < 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma.
Conclusions
FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.
FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>38450033</pmid><doi>10.1002/ams2.934</doi><tpages>5</tpages><orcidid>https://orcid.org/0009-0007-1004-9659</orcidid><orcidid>https://orcid.org/0000-0001-5651-1449</orcidid><orcidid>https://orcid.org/0000-0003-4104-386X</orcidid><orcidid>https://orcid.org/0009-0009-9980-1185</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2052-8817 |
ispartof | Acute medicine & surgery, 2024-01, Vol.11 (1), p.e934-n/a |
issn | 2052-8817 2052-8817 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4 |
source | Wiley-Blackwell Open Access Collection; Publicly Available Content (ProQuest); PubMed Central |
subjects | Accuracy blood coagulation diagnosis Emergency medical care emergency room fibrinogen Hemorrhage Molecular weight Original Patients Plasma Postpartum period trauma Viscoelasticity |
title | Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T17%3A57%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20rapid%20blood%20coagulation%20testing%20device%20FibCare%C2%AE%20in%20a%20tertiary%20emergency%20department&rft.jtitle=Acute%20medicine%20&%20surgery&rft.au=Mihara,%20Yutaka&rft.date=2024-01&rft.volume=11&rft.issue=1&rft.spage=e934&rft.epage=n/a&rft.pages=e934-n/a&rft.issn=2052-8817&rft.eissn=2052-8817&rft_id=info:doi/10.1002/ams2.934&rft_dat=%3Cproquest_doaj_%3E3150086566%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3150086566&rft_id=info:pmid/38450033&rfr_iscdi=true |